Mc Collum Christoferson Group LLC Virios Therapeutics, Inc. Transaction History
Mc Collum Christoferson Group LLC
- $328 Million
- Q3 2024
A detailed history of Mc Collum Christoferson Group LLC transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Mc Collum Christoferson Group LLC holds 33,500 shares of VIRI stock, worth $148,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,500
Previous 57,000
41.23%
Holding current value
$148,740
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VIRI
# of Institutions
28Shares Held
1.12MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA231KShares$1.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA209KShares$927,4400.0% of portfolio
-
Ubs Group Ag186KShares$826,1150.0% of portfolio
-
Hrt Financial LP New York, NY81.6KShares$362,1880.0% of portfolio
-
Two Sigma Securities, LLC New York, NY53.4KShares$237,0600.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $81.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...